Specific Biomarkers of Immune-mediated Hepatitis Secondary to Immune Checkpoint Inhibitors

Recruiting now

Conditions studied: Immune-mediated Hepatitis

In brief

Identify specific blood biomarkers for hepatitis induced by immune checkpoint inhibitors in comparison to idiopathic autoimmune hepatitis.

Key facts

Study ID

NCT06470997

Run by

University Hospital, Montpellier

People needed

60

Starts

2024-07-17

Expected to finish

2027-01-31

Last updated by the study team

2025-11-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• CHU de Montpellier — Montpellier, France, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.